China Money Network
Login
Join

Chinese Pre-Profit Cancer Drug Developer Tot Biopharm Files For HK IPO

  • May 3, 2019 — 11:00 CST

This Data Is Locked!

This area is available only to Subscribers.

Tot Biopharm, a private equity-backed Chinese biopharmaceutical company, has filed for an initial public offering (IPO) in Hong Kong on Monday under the rules that... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: